Author: OurCrowd

The media wants to know about crowdfunding: OurCrowd’s Jon Medved makes the rounds

On Sunday, OurCrowd’s CEO Jon Medved commenced a three-week tour across the US, accompanied by a coterie of OurCrowd portfolio companies, including Webydo and Parko (you’ll have to register to see more info about the companies we’re investing in currently). Jon’s trip began with an appearance with interviews with Bloomberg’s Pimm Fox and the CBC’s Lang and O’Leary Exchange. Bloomberg’s Pimm Fox talks crowdfunding with OurCrowd’s Jon Medved Jon Medved talks with Lang and O’Leary about how OurCrowd chooses investments Read the whole article   Meet up with Jon on his U.S. tour To find out where Jon is appearing next and meeting with investors, check out his upcoming...

Read More

[PRESS RELEASE] OurCrowd Begins General Solicitation of US Investors in Accordance with New SEC Regulations

Jerusalem, Israel September 23, 2013:OurCrowd, Israel’s leading equity crowdfunding platform for accredited investors, has begun general solicitation of US investors for deals in compliance with new regulations issued by the Securities and Exchange Commission (SEC) that go into effect today. Until now, OurCrowd and other equity crowdfunding platforms have been unable to generally solicit or generally advertise to US investors about investment opportunities. Read more here....

Read More

OurCrowd-Trendlines Roadshow underway across the US

Meet OurCrowd across the US, Israel and Australia in October at a series of roadshow events and speaking engagements. In the US, OurCrowd has partnered with The Trendlines Group to host four roadshow events featuring five Israeli medtech startups. Later in October, OurCrowd founder and CEO Jon Medved will be in Sydney and Melbourne. The Trendlines Group: Trendlines is Israel’s leading agritech and medtech incubator, with a portfolio of over 40 companies. OurCrowd members invested nearly $1M into Trendlines in early 2013, and OurCrowd is building and fundraising for the Trendlines portfolio as part of ongoing support for the Trendlines Group as an OurCrowd portfolio company. On October’s roadshow Trendlines is raising a round of finance for four biotech companies, which accredited investors can register to invest in via a dedicated site. About MST, the latest addition to OurCrowd’s portfolio and a company touring the US in October MST has developed a video analytics-driven robotic manipulator that tracks and follows surgical tools at the press of a button, allowing surgeons to move independently and hold laparoscopes in a stable,...

Read More